LIVIXIL PAK is a Topical Kit in the Human Prescription Drug category. It is labeled and distributed by Alvix Laboratories, Llc. The primary component is .
Product ID | 15455-9504_8088a895-c854-47f6-e053-2991aa0ad3be |
NDC | 15455-9504 |
Product Type | Human Prescription Drug |
Proprietary Name | LIVIXIL PAK |
Generic Name | Lidocaine 2.5% And Prilocaine 2.5% |
Dosage Form | Kit |
Route of Administration | TOPICAL |
Marketing Start Date | 2015-07-22 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Alvix Laboratories, LLC |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-07-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-07-22 |
SPL SET ID: | 1b839cb3-c1eb-3303-e054-00144ff88e88 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
15455-9504 | LIVIXIL PAK | lidocaine 2.5% and prilocaine 2.5% |
15455-9528 | AgonEaze | lidocaine 2.5% and prilocaine 2.5% |
69336-825 | LIDOPRIL | Lidocaine 2.5% and Prilocaine 2.5% |
69336-826 | LIDOPRIL XR | Lidocaine 2.5% and Prilocaine 2.5% |
69336-828 | PRILOLID | Lidocaine 2.5% and Prilocaine 2.5% |
72275-701 | PRILOVIX | lidocaine 2.5% and prilocaine 2.5% |
72275-710 | PRILOVIX Lite | lidocaine 2.5% and prilocaine 2.5% |
72275-711 | PRILOVIX Lite Plus | lidocaine 2.5% and prilocaine 2.5% |
72275-703 | PRILOVIX Plus | lidocaine 2.5% and prilocaine 2.5% |
72275-712 | PRILOVIX UltraLite | lidocaine 2.5% and prilocaine 2.5% |
72275-713 | PRILOVIX Ultralite Plus | lidocaine 2.5% and prilocaine 2.5% |
72275-725 | PRILOVIXIL | lidocaine 2.5% and prilocaine 2.5% |
72275-726 | PRILOVIXIL | lidocaine 2.5% and prilocaine 2.5% |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LIVIXIL PAK 88245245 not registered Live/Pending |
Innovate Research & Development, LLC 2018-12-29 |